Biotech Vanguard·Oct 21Bayer's BlueRock opens allogeneic solid-tumor plant in berlin as EMA rewrites potency rulesThe 2,800-square-meter facility is designed for 10,000 doses a year, but BlueRock's real wager is a 200-patient-per-batch model the…
CancerFax - Advanced Cancer Treatment·Oct 1For 13 Years, CAR-T Could Not Crack Solid Tumors. In 2026, China Approved the First OneSince the first CAR-T therapy was approved in 2017, every one that followed shared the same limit. They worked in blood cancers: leukemia…
CancerFax - Advanced Cancer Treatment·Sep 8The World’s First Approved Gene Therapy Wasn’t American, and It’s Been Quietly Treating Cancer for…Ask most people, even people who follow oncology news closely, which country approved the world’s first gene therapy for cancer, and almost…
Andrii Kuzovchykov·Aug 1CAR-T Is Leaving Blood Cancer BehindAll six FDA-approved CAR-T therapies treat blood cancer. But in the pipeline, solid tumors and autoimmune disease now outnumber it more…
Ketaki Bhagwat·Jun 25How Tumor Irradiation Could Expand the Therapeutic Window of CAR-T Cell TherapyCritical Appraisal of Navarre et al., Nature Cancer, June 2026.
Ketaki Bhagwat·May 21How Gain of Function Screens can Provide Novel Insights in Tumor infiltration and ImmunotherapyCritical Appraisal of Kim et al., Nature Immunology, May 2026.
Mabnus_bio·Apr 13rhIL-7-hyFc improves the efficacy of CAR-T cells in the treatment of solid tumorsBackground
